Compare stocks

Bachem Holding AG is a Swiss company specializing in the biotechnology and pharmaceutical industries. It focuses on the development and production of peptides and oligonucleotides for the pharmaceutical and biotech sectors. Its offerings include active pharmaceutical ingredients (APIs) and customized synthesis services. Founded in 1971, Bachem's headquarters is located in Bubendorf, Switzerland, with additional facilities in the United States, Europe, and Asia. The company is known for its extensive expertise in peptide chemistry and its strategic focus on innovation and quality in manufacturing, contributing to its competitive position in the global pharmaceuticals market.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.